| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.08 | 0.04 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.1 | 0.04 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.072 | 0.04 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.05 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.075 | 0.05 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.064 | 0.05 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.05 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.05 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.05 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.05 |